Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The individual treatment success rates are only 20 to 30% (1).
Patients suffering from Inflammatory Bowel Disease (IBD) mostly require lifelong treatment (15).
Many of these therapies are administered parenterally and have been associated with adverse events such as serious infections or malignancy. This highlights a significant unmet medical need to minimize symptoms and promote GI healing. Although these treatments have generally benefited patients, there are sign…